Persistent eosinophilia in 2 patients with eosinophilia-myalgia syndrome
✍ Scribed by Daniel J. Wallace
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 142 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract __Objective.__ To investigate the metabolism of L‐tryptophan (LT) via the kynurenine pathway in patients with the eosinophilia–myalgia syndrome (EMS). __Methods.__ Measurement of LT, L‐kynurenine, and quinolinic acid in plasma and cerebrospinal fluid (CSF) from subjects with EMS, from
physicians in New Mexico notified the New Mexico Department of Health and Environment of 3 patients with marked eosinophilia and severe. incapacitating myalgia who had been taking the amino acid L-tryptophan (orally) and whose illness, after thorough clinical evaluation, seemed both unusual and obsc
The clinical constellation of leukocytosis, thrombocytosis, and low or absent stainable neutrophil alkaline phosphatase (NAP) is considered characteristic of chronic myelogenous leukemia (CML) [l]. CML with eosinophilic differentiation (eosinophilic leukemia) is well described [2], and leukemia and